Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Vivos Therapeutics (VVOS) Times Interest Earned (2020 - 2022)

Vivos Therapeutics has reported Times Interest Earned over the past 3 years, most recently at -$150.19 for Q3 2022.

  • Quarterly Times Interest Earned rose 75.44% to -$150.19 in Q3 2022 from the year-ago period, while the trailing twelve-month figure was -$583.11 through Jun 2023, down 393.59% year-over-year, with the annual reading at -$304.36 for FY2021, 142.68% down from the prior year.
  • Times Interest Earned was -$150.19 for Q3 2022 at Vivos Therapeutics, up from -$188.22 in the prior quarter.
  • Over five years, Times Interest Earned peaked at $2177.5 in Q4 2021 and troughed at -$4061.0 in Q2 2021.
  • The 3-year median for Times Interest Earned is -$174.71 (2022), against an average of -$638.26.
  • The largest YoY upside for Times Interest Earned was 700.09% in 2021 against a maximum downside of 5722.38% in 2021.
  • A 3-year view of Times Interest Earned shows it stood at -$362.86 in 2020, then soared by 700.09% to $2177.5 in 2021, then tumbled by 106.9% to -$150.19 in 2022.
  • Per Business Quant, the three most recent readings for VVOS's Times Interest Earned are -$150.19 (Q3 2022), -$188.22 (Q2 2022), and -$174.71 (Q1 2022).